Integrated Filing — IndAS



General information about company

Scrip Code 539660
NSE Symbol BESTAGRO
MSEI Symbol NOTLISTED
ISIN INE052T01021
Name of company BEST AGROLIFE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 30-07-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment AGROCHEMICALS
Start date and time of board meeting 30-07-2026   15:30:00
End date and time of board meeting 30-07-2026   18:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NO SUCH EVENT DURING THE QUARTER



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 26,207.00 26,207.00
Other income 450.00 450.00
Total income 26,657.00 26,657.00
2 Expenses
(a) Cost of materials consumed 357.00 357.00
(b) Purchases of stock-in-trade 17,811.00 17,811.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (242.00) (242.00)
(d) Employee benefit expense 1,495.00 1,495.00
(e) Finance costs 767.00 767.00
(f) Depreciation, depletion and amortisation expense 147.00 147.00
(f) Other Expenses
1 Other Expenses 2,058.00 2,058.00
Total other expenses 2,058.00 2,058.00
Total expenses 22,393.00 22,393.00
3 Total profit before exceptional items and tax 4,264.00 4,264.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 4,264.00 4,264.00
6 Tax expense
7 Current tax 1,111.00 1,111.00
8 Deferred tax 11.00 11.00
9 Total tax expenses 1,122.00 1,122.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 3,142.00 3,142.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 3,142.00 3,142.00
17 Other comprehensive income net of taxes 16.00 16.00
18 Total Comprehensive Income for the period 3,158.00 3,158.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,547.00 3,547.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.89 0.89
Diluted earnings (loss) per share from continuing operations 0.89 0.89
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.89 0.89
Diluted earnings (loss) per share from continuing and discontinued operations 0.89 0.89
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
1 Remeasurement gain/ (loss) of defined benefit obligations 21.00 21.00
Total Amount of items that will be reclassified to profit and loss 21.00
4 Income tax relating to items that will be reclassified to profit or loss 5.00 5.00
5 Total Other comprehensive income 16.00 16.00





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 27-12-2024
Amount Raised 15,000.00
Report filed for Quarter ended 30-06-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CRISIL RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NOT APPLICABLE
Comments of the Audit Committee after review This statement as on June 30, 2026 was reviewed and approved by the Audit Committee at its meeting held on July 30, 2026.
Comments of the auditors, if any NONE
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital Expenditure The Board in its meeting held on June 27, 2026 took note of the lapse of warrants and approved the forfeiture of the initial amount of ₹37.50 crore received by the Company. This leads to revision in the allocation of the issue proceeds and the same are no longer available for utilization 5,000.00 0.00 0.00 0.00 Initial revision of proceeds from Rs. 70 crores to Rs. 50 crores due to non-receipt of upfront money from Excello Fin Lea Limited and Nova Global Opportunities Fund, Second revision in the cost of objects from Rs. 50 crores to 0 crores during the reported quarter, due to non-receipt of balance 75% of warrants amount with-in the prescribed time.
2 Working capital The Board in its meeting held on June 27, 2026 took note of the lapse of warrants and approved the forfeiture of the initial amount of ₹37.50 crore received by the Company. This leads to revision in the allocation of the issue proceeds and the same are no longer available for utilization 9,000.00 3,750.00 3,750.00 0.00 Initial revision of proceeds from Rs. 120 crores to Rs. 90 crores due to non-receipt of upfront money from Excello Fin Lea Limited and Nova Global Opportunities Fund, Second revision in the cost of objects from Rs. 90 crores to 37.50 crores during the reported quarter, due to non-receipt of balance 75% of warrants amount with-in the prescribed time.
3 General Corporate Purpose The Board in its meeting held on June 27, 2026 took note of the lapse of warrants and approved the forfeiture of the initial amount of ₹37.50 crore received by the Company. This leads to revision in the allocation of the issue proceeds and the same are no longer available for utilization 1,000.00 0.00 0.00 0.00 Revision in the cost of objects from Rs. 10 crores to 0 crores during the reported quarter, due to non-receipt of balance 75% of warrants amount with-in the prescribed time.


Signatory Details

Name of signatory Vikas Sohanlal Jain
Designation of person Chief Financial Officer
Place New Delhi
Date 30-07-2026